Peptides: who's using them and what's in them?

The popularity of peptides appears to be growing in Australia - what do we know about who is using them, what's in them and the risks?

A large study of Australians with Parkinson's disease finds links to certain pesticides and high-risk occupations.

For people with heart failure, there's a procedure that you can avoid with no ill-effect.

And an outbreak of diptheria across multiple states in Australia - how did this happen?

References

• Obesity and cardiovascular disease: A clinical consensus statement from the National Heart Foundation of Australia
• Impact and Effectiveness of Australia's 2025 Hybrid RSV Immunisation Program: Results from the PAEDS-FluCAN Network
• Diphtheria outbreak could be 'contained within months' but response criticised as too slow
• Responding to injectable synthetic peptide use among young people: priorities for clinicians and public health
• Insights from a cross-sectional population-based study of 10,929 Australians living with Parkinson's disease: risk factors, comorbidities, and sex differences
• Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial